trachoma vaccine
Vaccine development
vaccine preparations
Chlamydia Trachomatis vaccine
challenge of inducing vaccine
vaccine protocol ready
final vaccine candidate
ocular responses
main ocular serovars
ocular Chlamydia trachomatis infections
immuno-repeat technology
ocular non-human primate
sustained local ocular IgA
optimal ocular mucosal immunity
TRACVAC Consortium
main objectives
prime boost strategy
immuno-repeat construct
neglected infectious disease Trachoma
MOMP
neutralizing epitopes
clinical phase
challenge model
best strategy
use
high density array technology
global problem of blinding trachoma
immunization protocol
lack of neutralizing antibody responses
infectious diseases
different prime boost vaccination strategies
high endemic regions
early human proof of concept
B cell cloning
major outer membrane antigen
unique combination
NHP
bacterial strains
protection
malaria
topic
evaluation
protected individuals
aim
important bottlenecks
project
quantity
vaccines
summary
trial
quality